Antibody Responses Are Generated to Immunodominant ELK/KLE-Type Motifs on the Nonstructural-1 Glycoprotein during Live Dengue Virus Infections in Mice and Humans: Implications for Diagnosis, Pathogenesis, and Vaccine Design
about
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infectionsMonoclonal Antibodies That Bind to Common Epitopes on the Dengue Virus Type 2 Nonstructural-1 and Envelope Glycoproteins Display Weak Neutralizing Activity and Differentiated Responses to Virulent Strains: Implications for Pathogenesis and VaccinesEmerging Zika Virus Infection: A Rapidly Evolving SituationCurrent progress in dengue vaccinesProtection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.The NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease.Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines.Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.Epitope reactions can be gauged by relative antibody discriminating specificity (RADS) values supported by deletion, substitution and cysteine bridge formation analyses: potential uses in pathogenesis studies.Identification of a nonstructural DNA-binding protein (DBP) as an antigen with diagnostic potential for human adenovirusDifferentially expressed genes of human microvascular endothelial cells in response to anti-dengue virus NS1 antibodies by suppression subtractive hybridization.Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patientsCooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 AntigenPathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses.Expression, purification, and evaluation of diagnostic potential and immunogenicity of a recombinant NS3 protein from all serotypes of dengue virusDetermination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico.A simple, inexpensive, robust and sensitive dot-blot assay for equal detection of the nonstructural-1 glycoprotein of all dengue virus serotypes.Metadata-driven comparative analysis tool for sequences (meta-CATS): an automated process for identifying significant sequence variations that correlate with virus attributesThe human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.Dengue Virus NS1 Protein Modulates Cellular Energy Metabolism by Increasing Glyceraldehyde-3-Phosphate Dehydrogenase Activity.Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection.Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies.High-level expression of functionally active dengue-2 non-structural antigen 1 production in Escherichia coli.
P2860
Q24289014-F5C87095-3B36-45EC-9818-D6B3D9CDD564Q27485490-AAE0307B-F8AA-40B6-8A03-393C86ABEF34Q28114559-06FF203F-569C-49AB-8D6C-9BA0D81C9E1FQ33408300-090DEFC2-1B12-4872-9D08-953BA4FCC2F5Q33414156-57D7008A-7FAD-41B4-8545-4E111924719EQ33610555-47094643-672A-402D-9FD2-B821CCE66522Q33952146-13A0B794-97EF-405F-B18D-CF55284358A9Q34059579-059BA936-4F00-41E8-A33B-A00B36A48EDEQ34226542-296E221D-F99A-481A-8BC8-927A4EF979E1Q34251847-59A0F32F-4812-4D04-896F-7FCA162290D0Q34629297-71C4DE53-4F5C-4491-BFFD-EBBBD3182A7CQ34734522-68153EFC-40F4-4811-8B80-557CDB6D1940Q35590817-8370FA78-154F-4184-B0F4-3EED03BD19FDQ35864468-5E6F9D12-537F-4E9E-A361-EC780B68EB0FQ36267886-49E8D37D-11BE-4533-8894-A4DD40B25F4AQ36457958-7C860831-D243-4967-A1FB-B828502EBB1CQ36669080-BCCB695A-C804-4962-9E36-8D1BEC22C419Q36847198-2DA99497-3487-45B5-BBB1-FE8839B99026Q37292739-04DB4229-CD8C-474D-A72C-C77ED4C0732CQ37448171-6085AD6D-B7EC-43C6-B437-36C1D213DAC1Q38697863-3C48F03B-222E-494E-89A0-D0B7D89BC49CQ38834797-69D45EA0-F118-4F9F-B429-5B1BC650B544Q40045064-AC93A901-D9FC-4B98-842F-696E5E1DF457Q40062304-6D95E0AD-6528-480C-8860-A9CF31E15968Q40405263-63470372-D064-46CC-91F5-7094E39CE460Q42971438-5A056E70-5347-445B-81D5-B3A2C3794259
P2860
Antibody Responses Are Generated to Immunodominant ELK/KLE-Type Motifs on the Nonstructural-1 Glycoprotein during Live Dengue Virus Infections in Mice and Humans: Implications for Diagnosis, Pathogenesis, and Vaccine Design
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antibody Responses Are Generat ...... thogenesis, and Vaccine Design
@ast
Antibody Responses Are Generat ...... thogenesis, and Vaccine Design
@en
Antibody Responses Are Generat ...... thogenesis, and Vaccine Design
@nl
type
label
Antibody Responses Are Generat ...... thogenesis, and Vaccine Design
@ast
Antibody Responses Are Generat ...... thogenesis, and Vaccine Design
@en
Antibody Responses Are Generat ...... thogenesis, and Vaccine Design
@nl
prefLabel
Antibody Responses Are Generat ...... thogenesis, and Vaccine Design
@ast
Antibody Responses Are Generat ...... thogenesis, and Vaccine Design
@en
Antibody Responses Are Generat ...... thogenesis, and Vaccine Design
@nl
P2860
P921
P356
P1476
Antibody Responses Are Generat ...... thogenesis, and Vaccine Design
@en
P2093
Andrew K I Falconar
P2860
P304
P356
10.1128/CVI.00371-06
P577
2007-05-01T00:00:00Z